The JOINT CLINICAL PRACTICE GUIDELINE ON Bezodiazepine Tapering  Considerations when Benzodiazepine Risks Outweigh Benefits Benzodiazepine ASAM, USA, 2025 https://downloads.asam.org/sitefinity-production-blobs/docs/default-source/guidelines/…

ASAM. Benzodiazepine Tapering Developed by a multidisciplinary group led by ASAM, this guideline aims to assist clinicians in helping patients safely taper from their benzodiazepine medication, while minimizing withdrawal symptoms. (ASAM – Ame…

Safer supply programs: Discussions on medication diversion, sharing, and selling.  Haines M, Hill E, O'Byrne P.  Int J Drug Policy. 2025 Feb 5;137:104731. doi: 10.1016/j.drugpo.2025.104731. Epub ahead of print. PMID: 39914038. https://w…

Overcoming barriers to traditional care delivery and pharmacy challenges: a qualitative study of buprenorphine, telehealth, and a digital therapeutic for opioid use disorder.  Monico LB, Eastlick M, Michero D, Pielsticker P, Glasner S. …

Disparities in Substance Use Disorder Telehealth Services.  Walker LS, Cui M, Cantor J, et al.  JAMA Netw Open. 2025;8(2):e2459606. doi:10.1001/jamanetworkopen.2024.59606 https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2830…

Methylphenidate and (lis)dexamfetamine toxicity-related deaths of adults, Australia, 2000-24: analysis of NCIS data.  Darke S, Peacock A, Duflou JA, Farrell M, Lappin J.  Med J Aust. 2025 Feb 18. doi: 10.5694/mja2.52604. Epub ahead of pr…